188 related articles for article (PubMed ID: 9507929)
21. Regional specificity of ethanol and NMDA action in brain revealed with FOS-like immunohistochemistry and differential routes of drug administration.
Knapp DJ; Braun CJ; Duncan GE; Qian Y; Fernandes A; Crews FT; Breese GR
Alcohol Clin Exp Res; 2001 Nov; 25(11):1662-72. PubMed ID: 11707641
[TBL] [Abstract][Full Text] [Related]
22. Effects of differential rearing on amphetamine-induced c-fos expression in rats.
Gill MJ; Weiss ML; Cain ME
Drug Alcohol Depend; 2014 Dec; 145():231-4. PubMed ID: 25454411
[TBL] [Abstract][Full Text] [Related]
23. Effect of modafinil on cerebral blood flow of anaesthetised rats. Comparison with amphetamine.
Florence G; Bonnier R; Plagnes D; Piérard C; Satabin P; Pérès M; Lagarde D
Exp Brain Res; 2000 Dec; 135(4):552-6. PubMed ID: 11156319
[TBL] [Abstract][Full Text] [Related]
24. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.
Chapotot F; Pigeau R; Canini F; Bourdon L; Buguet A
Psychopharmacology (Berl); 2003 Mar; 166(2):127-38. PubMed ID: 12552359
[TBL] [Abstract][Full Text] [Related]
25. Chronic food restriction increases fos-like immunoreactivity (FLI) induced in rat forebrain by intraventricular amphetamine.
Carr KD; Kutchukhidze N
Brain Res; 2000 Apr; 861(1):88-96. PubMed ID: 10751568
[TBL] [Abstract][Full Text] [Related]
26. Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons.
McPherson CS; Featherby T; Krstew E; Lawrence AJ
J Pharmacol Exp Ther; 2007 Dec; 323(3):805-12. PubMed ID: 17878407
[TBL] [Abstract][Full Text] [Related]
27. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.
Dopheide MM; Morgan RE; Rodvelt KR; Schachtman TR; Miller DK
Eur J Pharmacol; 2007 Jul; 568(1-3):112-23. PubMed ID: 17477916
[TBL] [Abstract][Full Text] [Related]
28. Promoting of wakefulness by administrations of modafinil into anterior hypothalamus and into the pedunculopontine tegmental nucleus in rats.
Murillo-Rodríguez E; Vázquez-Luis E; Millán-Aldaco D; Haro R; Drucker-Colín R
Neurosci Lett; 2008 May; 436(2):283-7. PubMed ID: 18403119
[TBL] [Abstract][Full Text] [Related]
29. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
[TBL] [Abstract][Full Text] [Related]
30. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
Edgar DM; Seidel WF
J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
[TBL] [Abstract][Full Text] [Related]
31. Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain.
Ostrander MM; Badiani A; Day HE; Norton CS; Watson SJ; Akil H; Robinson TE
Neuroscience; 2003; 120(2):551-71. PubMed ID: 12890524
[TBL] [Abstract][Full Text] [Related]
32. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.
Lin JS; Gervasoni D; Hou Y; Vanni-Mercier G; Rambert F; Frydman A; Jouvet M
J Sleep Res; 2000 Mar; 9(1):89-96. PubMed ID: 10733694
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
[TBL] [Abstract][Full Text] [Related]
34. Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity.
Akaoka H; Roussel B; Lin JS; Chouvet G; Jouvet M
Neurosci Lett; 1991 Feb; 123(1):20-2. PubMed ID: 1676498
[TBL] [Abstract][Full Text] [Related]
35. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study.
Gallopin T; Luppi PH; Rambert FA; Frydman A; Fort P
Sleep; 2004 Feb; 27(1):19-25. PubMed ID: 14998233
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.
Quisenberry AJ; Baker LE
Psychopharmacology (Berl); 2015 Dec; 232(24):4411-9. PubMed ID: 26374456
[TBL] [Abstract][Full Text] [Related]
37. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.
Singewald N; Salchner P; Sharp T
Biol Psychiatry; 2003 Feb; 53(4):275-83. PubMed ID: 12586446
[TBL] [Abstract][Full Text] [Related]
38. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
Paterson NE; Fedolak A; Olivier B; Hanania T; Ghavami A; Caldarone B
Pharmacol Biochem Behav; 2010 Jun; 95(4):449-56. PubMed ID: 20346966
[TBL] [Abstract][Full Text] [Related]
39. Behavioral sensitization to amphetamine is not accompanied by a decrease in the number of c-Fos containing cells in the striatum.
Turgeon SM; Blum JE; Auerbach EA
Brain Res; 1998 Jan; 782(1-2):329-32. PubMed ID: 9519282
[TBL] [Abstract][Full Text] [Related]
40. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats.
Hou YP; Lin JS
Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):813-8. PubMed ID: 11245089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
